Literature DB >> 16191301

[Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].

Qian Peng1, Tong-fu Zhou, Chang-hui Chen, Yi-min Hua, Han-min Liu, Hua Hong, Ling-ying Zhang, Qing Wu.   

Abstract

OBJECTIVE: Kawasaki disease (KD) complicated with coronary artery lesion (CAL) seriously threatens survival quality and life of patients, suggesting that it is very important to early predict the risk of CAL and to early diagnose the disease. Nevertheless, up to now there has been no specific clinical biochemical marker for it because of the poor understanding of the pathological process of KD with CAL. Matrix metalloproteinases (MMPs) and their specific tissue inhibitor of metalloproteinases (TIMPs) play an important role in arterial wall extracellular matrix breakdown and remodeling and are involved in CAL in other diseases. In the present study the practical value of serum MMP-9 and TIMP-1 levels in the prediction and early diagnosis of CAL in KD patients was investigated.
METHODS: All subjects were from Chinese population. Serum levels of MMP-9 and TIMP-1 were measured by rapid one-step sandwich enzyme immunoassay in 59 KD patients including 15 with CAL and 44 without CAL by 2 D-echocardiography and coronary angiography, and 20 normal healthy children as controls. Blood samples of patients were obtained before and after intravenous immunoglobulin (IVIG) treatment in acute stage, subacute stage and convalescent stage as well. Serum MMP-9 and TIMP-1 levels and the ratio of MMP-9/TIMP-1 were compared by statistical method in KD patients and controls, as well as in KD with CAL and without CAL.
RESULTS: In acute stage serum MMP-9 and TIMP-1 levels and the ratio of MMP-9/TIMP-1 were higher (P < 0.01) in patients with KD than those in healthy children. After IVIG treatment in KD patients serum MMP-9 level and the ratio of MMP-9/TIMP-1 decreased (P < 0.01). Before IVIG treatment serum MMP-9 level and the ratio of MMP-9/TIMP-1 were higher (P < 0.01) in patients with CAL than those in patients without CAL, and in acute stage after IVIG treatment serum MMP-9 level of KD patients with CAL was still higher than that of KD patients without CAL.
CONCLUSION: In acute stage of KD serum MMP-9 level and the ratio of MMP-9/TIMP-1 were higher in patients with CAL than those in patients without CAL, suggesting that during acute phase of KD the great increase in serum MMP-9 and the imbalance of the MMP-9/TIMP-1 ratio might be high risk factors of KD coronary artery lesion. Therefore, the measurement of serum MMP-9 and TIMP-1 might be of important clinical value in the prediction and the early diagnosis of KD with coronary artery lesion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16191301

Source DB:  PubMed          Journal:  Zhonghua Er Ke Za Zhi        ISSN: 0578-1310


  6 in total

1.  A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants.

Authors:  Karl G Sylvester; Xuefeng B Ling; G Y Liu; Zachary J Kastenberg; Jun Ji; Zhongkai Hu; Sihua Peng; Ken Lau; Fizan Abdullah; Mary L Brandt; Richard A Ehrenkranz; Mary Catherine Harris; Timothy C Lee; Joyce Simpson; Corinna Bowers; R Lawrence Moss
Journal:  Gut       Date:  2013-09-18       Impact factor: 23.059

2.  Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population.

Authors:  Ju Yeon Ban; Kyung Leem Yoon; Su Kang Kim; Sungwook Kang; Joo-Ho Chung
Journal:  Pediatr Cardiol       Date:  2008-12-02       Impact factor: 1.655

3.  A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses.

Authors:  Xuefeng B Ling; Kenneth Lau; John T Kanegaye; Zheng Pan; Sihua Peng; Jun Ji; Gigi Liu; Yuichiro Sato; Tom T S Yu; John C Whitin; James Schilling; Jane C Burns; Harvey J Cohen
Journal:  BMC Med       Date:  2011-12-06       Impact factor: 8.775

4.  The Predictive Values of MMP-9, PLTs, ESR, and CRP Levels in Kawasaki Disease with Cardiovascular Injury.

Authors:  Yinan Yang; Xiaobin Hu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-14       Impact factor: 2.650

5.  Role of the PTEN/PI3K/VEGF pathway in the development of Kawasaki disease.

Authors:  Xinjiang An; Haitao Lv; Jing Tian; Xiuhua He; Nan Ling
Journal:  Exp Ther Med       Date:  2016-01-27       Impact factor: 2.447

6.  Serum Levels of Syndecan-1 in Patients With Kawasaki Disease.

Authors:  Li Luo; Siqi Feng; Yao Wu; Ya Su; Fengchuan Jing; Qijian Yi
Journal:  Pediatr Infect Dis J       Date:  2019-01       Impact factor: 2.129

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.